Effect of catheter ablation on progression of paroxysmal atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 1, 2012, Pages 9-14

  Jongnarangsin, Krit ^a   Suwanagool, Arisara ^a   Chugh, Aman ^a   Crawford, Thomas ^a   Good, Eric ^a   Pelosi Jr , Frank ^a   Bogun, Frank ^a   Oral, Hakan ^a   Morady, Fred ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

antiarrhythmic drugs; atrial fibrillation; heart failure; radiofrequency catheter ablation

Indexed keywords

ADULT; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HATCH SCORE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SCORING SYSTEM; SINUS RHYTHM; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CATHETER ABLATION; DIABETES COMPLICATIONS; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MICHIGAN; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84855995797     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2011.02137.x     Document Type: Article

References (17)

1. Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL, Packer DL, Hammill SC, Shen WK, Gersh BJ,: Long-term progression and outcomes with aging in patients with lone atrial fibrillation: A 30-year follow-up study. Circulation 2007; 115: 3050-3056. (Pubitemid 46956493)
2. de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, van den Heijkant AC, Allessie MA, Crijns HJ,: Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 55: 725-731.
3. Kerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, Boone J, Sheldon R, Dorian P, Newman D,: Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation. Am Heart J 2005; 149: 489-496. (Pubitemid 40585413)
4. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ,: HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm 2007; 4: 816-861. (Pubitemid 46850611)
5. Allessie M, Ausma J, Schotten U,: Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002; 54: 230-246. (Pubitemid 34327903)
6. Allessie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, Van Wagoner DR, Waldo AL,: Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103: 769-777. (Pubitemid 32144209)
7. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA,: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-68.
8. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr,., Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL,: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8: 651-745. (Pubitemid 44472247)
9. Burstein B, Nattel S,: Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008; 51: 802-809. (Pubitemid 351260071)
10. Eckstein J, Verheule S, de Groot NM, Allessie M, Schotten U,: Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria. Prog Biophys Mol Biol 2008; 97: 435-451.
11. Abe Y, Fukunami M, Yamada T, Ohmori M, Shimonagata T, Kumagai K, Kim J, Sanada S, Hori M, Hoki N,: Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography: A prospective study. Circulation 1997; 96: 2612-2616. (Pubitemid 27451353)
12. Koide Y, Yotsukura M, Sakata K, Yoshino H, Ishikawa K,: Investigation of the predictors of transition to persistent atrial fibrillation in patients with paroxysmal atrial fibrillation. Clin Cardiol 2002; 25: 69-75. (Pubitemid 34111557)
13. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, Aizawa Y,: Metabolic syndrome and risk of development of atrial fibrillation: The Niigata preventive medicine study. Circulation 2008; 117: 1255-1260. (Pubitemid 351365676)
14. Pappone C, Radinovic A, Manguso F, Vicedomini G, Ciconte G, Sacchi S, Mazzone P, Paglino G, Gulletta S, Sala S, Santinelli V,: Atrial fibrillation progression and management: A 5-year prospective follow-up study. Heart Rhythm 2008; 5: 1501-1507.
15. Pretorius L, Du XJ, Woodcock EA, Kiriazis H, Lin RC, Marasco S, Medcalf RL, Ming Z, Head GA, Tan JW, Cemerlang N, Sadoshima J, Shioi T, Izumo S, Lukoshkova EV, Dart AM, Jennings GL, McMullen JR,: Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. Am J Pathol 2009; 175: 998-1009.
16. Lee SH, Chen YC, Cheng CC, Higa S, Chen YJ, Chen SA,: Hypertonicity increases rabbit atrium and pulmonary vein arrhythmogenesis: A potential contributor to the genesis of atrial fibrillation. Clin Exp Pharmacol Physiol 2009; 36: 419-424.
17. Zaman AK, Fujii S, Sawa H, Goto D, Ishimori N, Watano K, Kaneko T, Furumoto T, Sugawara T, Sakuma I, Kitabatake A, Sobel BE,: Angiotensin- converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice. Circulation 2001; 103: 3123-3128. (Pubitemid 32587861)